Companies / Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc

Nasdaq: ENTACIK 1177648WATERTOWN, MA

Financials · FY2025

Revenue$65.32M
Net income$-81.89M
Total debt—
Cash$33.42M
Diluted EPS$-3.84
Shares outstanding29.1M

Ownership

29.1M shares outstanding · as of Aug 7, 2026
4.6%Insiders
Ownership
Insiders4.64%1,351,129
10%+ / strategic6.72%1,956,867
Institutions84.96%24,745,090
Public float3.68%1,072,316

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Luly Jay R.CEOPresident and CEO · Director
2.99%871,871
Or Yat SunChief Scientific Officer
1.29%374,854
Luu BrendanChief Business Officer
0.14%41,634
Kieffer Tara LynnChief Product Strategy Officer
0.12%33,925
Rottinghaus Scott T.Chief Medical Officer
0.09%25,254
Kowalsky Matthew PaulChief Legal Officer
0.01%3,591
Carter Bruce L aDirector
——
Foletta Mark GDirector
——
Hata Yujiro SDirector
——
Peterson KristineDirector
——

Institutional holders 133

View all →
HolderValue% of shares
Janus Henderson Group PLC$47.72M12.99%
BlackRock, Inc.$47.30M11.14%
Farallon Capital Management LLC$43.72M9.52%
Vanguard Group Inc$36.30M7.90%
Deep Track Capital, LP$30.86M6.72%
Millennium Management LLC$11.14M3.03%
Geode Capital Management, LLC$9.16M2.49%
Renaissance Technologies LLC$8.40M2.28%
State Street Corporation$8.40M1.98%
Point72 Asset Management, L.P.$6.92M1.51%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 12, 2026Luly Jay R.
CEO
OtherCommon Stock$87.7K-6K
-0.70%
871,871
2.99% of shares
low
Feb 12, 2026Or Yat Sun
Executive
OtherCommon Stock$48.6K-3K
-0.90%
374,854
1.29% of shares
low
Feb 12, 2026Rottinghaus Scott T.
Executive
OtherCommon Stock$48.6K-3K
-11.91%
25,254
0.09% of shares
low
Feb 12, 2026Luu Brendan
Executive
OtherCommon Stock$46.4K-3K
-7.26%
41,634
0.14% of shares
low
Feb 12, 2026Kieffer Tara Lynn
Executive
OtherCommon Stock$46.4K-3K
-8.76%
33,925
0.12% of shares
low
Feb 12, 2026Kowalsky Matthew Paul
Executive
OtherCommon Stock$27.1K-2K
-34.63%
3,591
0.01% of shares
low
Feb 12, 2026Luu Brendan
Executive
GrantCommon Stock$0+5K
+12.50%
44,891
0.15% of shares
low
Feb 12, 2026Luu Brendan
Executive
GrantCommon Stock$0+2K
+4.11%
39,904
0.14% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Farallon Capital Partners, L.P.Passive13G/A———
Integrated Core Strategies (US) LLCPassive13G/A———
Deep Track Capital, LPPassive13G/A—1,956,867—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ENTA——29251M106—